Cancers can cause pulmonary embolism, and an unprovoked PE may signal an undiscovered cancer lurking in the body. In older studies, as many as 1 in 10 patients with unprovoked PE were diagnosed with cancer within a year. (The current terminology is that a PE is provoked if associated with a known cancer or another provoking factor, but [... read more]
The post Limited cancer screening seems appropriate after unprovoked PE appeared first on PulmCCM.
New oral anticoagulants like dabigatran, apixaban and rivaroxaban have advantages over warfarin: not requiring regular monitoring for efficacy; faster onset of action; shorter half-lives. Unlike warfarin, they've had the significant disadvantage of having no proven antidote for the bleeding that inevitably occurs when any anticoagulant is given to thousands of people. [lawsuits] Boehringer Ingelheim, makers [... read more]
The post Idarucizumab works as antidote for dabigatran-induced bleeding appeared first on PulmCCM.
image: Wikipedia There’s only one sure way to prevent complications from a central line: don’t place one. Like many invasive interventions, central venous catheters’ indications have been called into question in recent years. Monitoring of central venous pressure and central venous oxygen saturation via central IV access — once considered essential to good care of severe [... read more]
The post Are central lines really needed for vasopressor infusions? appeared first on PulmCCM.
ATS Releases New Idiopathic Pulmonary Fibrosis Treatment Guidelines Recent Studies Bring New Recommendations by Lekshmi Santosh, MD This month, the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society and Latin American Thoracic Association released their updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF). They are free on the ATS website for all to peruse, but [... read more]
The post 2015 ATS Guidelines on Treatment of IPF Released appeared first on PulmCCM.
... not you. Sorry, that's a pretty mean way to start out someone's Monday. The brand new edition of Murray & Nadel's Textbook of Respiratory Medicine goes to Craig Scanlan of New Jersey. Congratulations, Craig! If you were among the non-winners, you can buy the new edition from the publisher for a paltry $319.99 -- [... read more]
The post And the winner of the Murray & Nadel books is … appeared first on PulmCCM.
Murray & Nadel's Textbook of Respiratory Medicine is the undisputed heavyweight champion of references in pulmonology. (The double volume set actually weighs in at a svelte 13.6 pounds). When a new edition comes out -- like the brand-new 6th edition edited by V. Courtney Broaddus, now available -- it's a big deal. You can buy [... read more]
The post Win a copy of the new Murray & Nadel 6th Edition appeared first on PulmCCM.